White Smile Global Inc. (WSML) Appoints Matthew E. Silpe to the Company's Board of Directors

"As we continue to scale our business and explore new growth opportunities, we are adding industry thought leaders to our team," said White Smile Global Inc. founder and CEO Omar Ahmadzai. "With his years of leadership experience at June Jacobs Laboratories combined with decades of experience in finance industries, Mr. Silpe is a seasoned industry veteran who is ideally suited help guide our Company as a key board member. "

Chief Scientific Officer and Board Member Dr. Martin S. Giniger DMD, PhD, MsD, FICD states, "I have known Matthew for some time now, and both he and his laboratory operate at the highest level of effectiveness." Over a phone interview after the announcement newly elected Board Member Matthew Silpe made the following statement, "The daily ritual of brushing one's teeth involves the use of abrasives and detergents that are virtually unchanged for the past 50 years. White Smile(TM) has one of the greatest scientific minds in the business in Dr. Giniger, a true pioneer, who's next generation oral health products are so revolutionary they will cause a complete shift in the way leading consumer product companies and dental professionals look at the practice of oral care."

About Matthew E. Silpe

Matthew Silpe is the COO of June Jacobs Labs, a personal care contract manufacturer based in Moonachie, NJ, where he is involved in managing all aspects of sales and operations at the company. Since joining JJ Labs as COO in late 2005, Mr. Silpe was responsible for dramatically transforming an underperforming asset into an exciting, profitable and rapidly growing operation, now more than 100 employees strong. By attracting new talent, upgrading the capital equipment and facilities, renegotiating with suppliers, streamlining operations, implementing new operating procedures, and bringing a marketing plan in to focus, sales more than doubled within two years, and doubled again two years later, while earlier losses were converted into profitability.

Mr. Silpe's experience in finance and real estate span more than 20 years. Prior to forming Millennium Capital Group, with a focus on early-stage capital raising and private placements, he was a senior business development officer with Talmage Capital, responsible for origination of investment banking opportunities involving various corporate finance activities, including capital raising, advisory and mergers and acquisitions. Previously, Matthew led the Private Equity Group at a US subsidiary of an investment group based in London, and held senior associate positions in real estate at Morgan Stanley Capital Markets and at GE Capital. He is currently the President of his Manhattan based Coop Association, and serves on the Board of several private companies and charitable organizations.

Mr. Silpe attended the University of Pennsylvania where he received a BA in Economics, and is a graduate of the NYU Stern School of Business where he received an MBA in Finance and International Business.

About the Company

White Smile Global Inc. is a vertically integrated Company that was created with the intent of offering the most effective, cutting edge technologies to the Cosmetic Dental Industry both domestically and abroad. The Company core focus is on the OTC Teeth Whitening and Oral Health industry. White Smile(TM) products are part of a large portfolio of patent-pending intellectual property centered on cutting edge technology and next-gen science. The Company has multiple offices worldwide with its headquarters in South Beach Miami Florida. All White Smile(TM) products are manufactured in FDA Registered Laboratories in America.

For more information visit http://www.whitesmileglobal.com.

For more information please contact:

White Smile Global Inc. Toll Free: 1.888.WSMILE1

General Information: info@whitesmileglobal.com

FORWARD LOOKING STATEMENT

This announcement is not an offer to sell any White Smile Global ("WSML") or related securities. Offers for any given security are made only through applicable offering circulars and related documents filed with the SEC pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934. Certain statements contained herein and subsequent oral statements made by and on behalf of WSML may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends," "anticipates," "believes," "expects," and "hopes" and includes, without limitation, statements regarding WSML's plan of business operations, product research and development activities, anticipated revenues and expenses and potential contractual arrangements and obligations. Also, our management may make forward-looking statements orally to investors, analysts, the media and others. Forward-looking statements express our expectations or predictions of future events or results. They are not guarantees and are subject to many risks and uncertainties. There are a number of factors beyond our control that could cause actual events or results to be significantly different from those described in the forward-looking statements. Any or all of our forward-looking statements in this report or in any other public statements we make may turn out to be wrong. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise.